Hoping for a good quarterly, with the new customers bringing revenue this quarter it will be interesting to see why difference they make. Plus would be a nice push in the share price with the momentum at the moment.
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025